Hays
Article Abstract:
Hays is a UK company providing business support services, and has boosted profits by 12% to 55.2 million pounds sterling for its core distribution operations. The company has cut exposure to food distribution in the UK where margins are low. Hays' personnel division has grown, accounting for 25% of operating profit for the year to Jun 1995. Hays' profit is forecast at 130 million pounds sterling for 1996, and 146 million pounds for 1997 by Panmure Gordon.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Tibbett and Britten
Article Abstract:
Tibbett and Britten is a UK logistics concern which has seen problems with Axial, its car distribution division. Computer crashes have created problems and costs have risen, with losses likely to rise to 10 million pounds sterling by the end of 1995. Closer links with Ford, the largest client, should ease problems in 1996. The group has seen a rise in turnover but spending is also increasing. The group's share price is seen as high enough in Sep 1995.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Uniq to demerge Wincanton
Article Abstract:
Uniq plans a demerger for Wincanton, which specialises in logistics, as a way of shedding non-core activities.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Safety net. The invisible man
- Abstracts: Tattered garments. Marling Industries. Colefax
- Abstracts: McBride. Procter and Gamble. Reckitt Benckiser
- Abstracts: The impact of dividends, debt and investment on valuation models. Determinants of capital structure and adjustment to long run target: evidence from UK company panel data
- Abstracts: Big business is high on the Honolulu method. A freeze-dryer and a fertile imagination. GlaxoSmithKline presents a biotech facade